HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CTFA guidelines

This article was originally published in The Rose Sheet

Executive Summary

Public comments on two revised Safety Evaluation Guidelines addressing Mucous Membrane Irritation and Controlled Use Testing in personal care and cosmetic products are requested by Feb. 20, Cosmetic, Toiletry and Fragrance Association announces Jan. 23. Mucous Membrane Irritation guideline "describes in vivo, in vitro, and clinical test methods for evaluating irritation potential" while the Controlled Use Testing guideline "describes controlled use studies in humans," association notes. Electronic copies of guidelines are available from the CTFA Public Affairs Department...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013669

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel